To test whether similar effects were observed in mouse models of cancer, we took Rnpc3 heterozygous mice (Doggett et al, 2018) and confirmed they exhibited a 50% decrease in Rnpc3 mRNA by RT-qPCR in two organs of interest, lung and stomach (Fig. 3A). This evidence concerns the gene RNPC3 and cancer.